Target Name: FSD1
NCBI ID: G79187
Review Report on FSD1 Target / Biomarker Content of Review Report on FSD1 Target / Biomarker
FSD1
Other Name(s): GLFND | Microtubule-associated protein GLFND | fibronectin type III and SPRY domain containing 1 | MID1-related protein 1 | MGC3213 | microtubule-associated protein GLFND | FSD1_HUMAN | fibronectin type 3 and SPRY domain containing 1 | midline 1-related protein 1 | Fibronectin type III and SPRY domain-containing protein 1 (isoform 1) | Midline 1-related protein 1 | FSD1 variant 1 | fibronectin type 3 and SPRY (spla, ryanodine) domain containing (with coiled-coil motif) 1 | Fibronectin type 3 and SPRY domain containing 1 | MIR1 | Fibronectin type 3 and SPRY (spla, ryanodine) domain containing (with coiled-coil motif) 1 | Fibronectin type III and SPRY domain containing 1, transcript variant 1 | Fibronectin type III and SPRY domain-containing protein 1

FSD1: A Protein Involved in Neural Development and Function

FSD1 (GLFND) is a protein that is expressed in various tissues throughout the body, including the nervous system, endocrine system, and muscle system. It is a member of the G protein-coupled receptor (GPCR) family, which is a large family of transmembrane proteins that play a key role in cellular signaling.

FSD1 is known for its role in the regulation of neural development and function. It is expressed in the developing brain and plays a critical role in the formation of neural connections and the development of neural circuits. In addition, FSD1 is also expressed in other tissues, including the muscle system, where it is involved in the regulation of muscle growth and function.

FSD1 has also been shown to play a key role in the regulation of various signaling pathways that are involved in inflammation, pain, and other inflammatory diseases. For example, studies have shown that FSD1 is involved in the regulation of pain perception and the modulation of pain responses. In addition, FSD1 has also been shown to play a key role in the regulation of inflammation, with studies showing that it is involved in the regulation of inflammation in various tissues.

FSD1 is also a potential drug target, as various studies have shown that it is involved in a wide range of cellular processes that are involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. In addition, FSD1 has also been shown to be involved in the regulation of cellular processes that are involved in the development and progression of various types of cancer, including breast, lung, and ovarian cancer.

In addition to its potential clinical applications, FSD1 is also a valuable research tool for the study of GPCR signaling pathways and the regulation of various cellular processes. Many researchers are interested in studying the role of FSD1 in these processes, as well as its potential as a drug target.

Overall, FSD1 is a protein that is involved in a wide range of cellular processes that are important for the development and function of the nervous system and other tissues. Its potential as a drug target makes it an attractive target for the study of GPCR signaling pathways and the regulation of various cellular processes.

Protein Name: Fibronectin Type III And SPRY Domain Containing 1

Functions: May be involved in microtubule organization and stabilization

The "FSD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FSD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

FSD1L | FSD2 | FSHB | FSHR | FSIP1 | FSIP2 | FSIP2-AS2 | FST | FSTL1 | FSTL3 | FSTL4 | FSTL5 | FTCD | FTCDNL1 | FTH1 | FTH1P1 | FTH1P10 | FTH1P11 | FTH1P12 | FTH1P2 | FTH1P20 | FTH1P22 | FTH1P24 | FTH1P3 | FTH1P4 | FTH1P5 | FTH1P7 | FTH1P8 | FTHL17 | FTL | FTLP16 | FTLP2 | FTLP3 | FTLP7 | FTMT | FTO | FTO-IT1 | FTOP1 | FTSJ1 | FTSJ3 | FTX | FUBP1 | FUBP3 | FUCA1 | FUCA2 | Fucosyl GM1 | Fucosyltransferase | FUNDC1 | FUNDC2 | FUNDC2P2 | FUNDC2P3 | FUOM | FURIN | FUS | FUT1 | FUT10 | FUT11 | FUT2 | FUT3 | FUT4 | FUT5 | FUT6 | FUT7 | FUT8 | FUT8-AS1 | FUT9 | FUZ | FXN | FXR1 | FXR2 | FXYD1 | FXYD2 | FXYD3 | FXYD4 | FXYD5 | FXYD6 | FXYD6-FXYD2 | FXYD7 | FYB1 | FYB2 | FYCO1 | FYN | FYTTD1 | FZD1 | FZD10 | FZD10-AS1 | FZD2 | FZD3 | FZD4 | FZD4-DT | FZD5 | FZD6 | FZD7 | FZD8 | FZD9 | FZR1 | G protein-Coupled Inwardly-Rectifying Potassium Channel (GIRK) | G Protein-Coupled Receptor Kinases (GRKs) | G0S2 | G2E3